AbbVie
ABBV
2,016 hedge funds and large institutions have $106B invested in AbbVie in 2018 Q1 according to their latest regulatory filings, with 133 funds opening new positions, 659 increasing their positions, 1,005 reducing their positions, and 92 closing their positions.
45% more first-time investments, than exits
New positions opened: 133 | Existing positions closed: 92
1% more funds holding
Funds holding: 2,001 → 2,016 (+15)
0.38% more ownership
Funds ownership: 70.57% → 70.95% (+0.38%)
2% less capital invested
Capital invested by funds: $109B → $106B (-$2.43B)
16% less funds holding in top 10
Funds holding in top 10: 164 → 137 (-27)
25% less call options, than puts
Call options by funds: $857M | Put options by funds: $1.14B
34% less repeat investments, than reductions
Existing positions increased: 659 | Existing positions reduced: 1,005
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$674M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$660M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$638M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$384M |
| 5 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
+$384M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Farm Mutual Automobile Insurance
Bloomington,
Illinois
|
-$581M |
| 2 |
Jennison Associates
New York
|
-$567M |
| 3 |
EIP
Epoch Investment Partners
New York
|
-$504M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$371M |
| 5 |
State Street
Boston,
Massachusetts
|
-$351M |
ABBV Hedge Fund Activity: Q1 2018 in Review
2,016 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q1 2018, worth a combined $106B — down 2.2% from $109B a quarter earlier.
Buyers outnumbered sellers: 133 funds opened new ABBV positions and 92 closed out — a net gain of 41 holders — while 659 added to existing stakes and 1,005 trimmed.
The largest buyer was Arrowstreet Capital, adding an estimated $674M. The largest seller was State Farm Mutual Automobile Insurance, cutting an estimated $581M.
- 2,016 institutional investors held AbbVie (ABBV) as of Q1 2018, up from 2,001 in Q4 2017.
- Funds reported $106B of AbbVie stock for Q1 2018, down 2.2% quarter-over-quarter.
- 133 funds opened new AbbVie positions in Q1 2018 and 92 closed out, a net change of +41 holders.
- The largest AbbVie buyer in Q1 2018 was Arrowstreet Capital, an estimated $674M added.
- The largest AbbVie seller in Q1 2018 was State Farm Mutual Automobile Insurance, an estimated $581M sold.
Based on aggregated 13F filings for Q1 2018.